Literature DB >> 27544663

Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms.

Kathrin A Limberger1,2, Lioudmila Bogatyreva3, Rumyana Todorova1, Bettina Herde1,4, Dieter Hauschke3, Heike L Pahl5, Martin Werner1, Konrad Aumann6.   

Abstract

Tissue microarray (TMA) technique is an established high-throughput method to analyze multiple tissue specimens in parallel. However, in order to obtain reliable results from immunohistochemical analyses of TMA blocks, cell composition of TMA spots must correspond to whole tissue sections (WTS) particularly in tissues with a heterogeneous cell composition as it is the case in myeloproliferative neoplasms (MPN). The aim of this study was to validate TMA of bone marrow biopsies from MPN patients. TMAs of MPN bone marrow biopsies (ET: n = 26, PV: n = 26, and PMF: n = 29) were compiled in triplicates and MPN-specific histological parameters were assessed. Results of TMA spots were compared with WTS' results using the intra-class correlation coefficient (ICC). Immunohistochemical NFE2 and calreticulin stainings of the TMA with quantitative evaluation were performed. TMA construction was technically successful with a loss of 10 % of all spots. ICC calculation revealed high to moderate correlations of TMA with WTS, especially the parameters that are typically affected in MPN tissue, e.g. cellularity of hematopoiesis (ICC 0.62-0.89), number of megakaryocytes (ICC 0.50-0.71), micro-vessel density (ICC 0.56-0.91), or grade of myelofibrosis (ICC 0.56-0.89). Results of NFE2 and calreticulin immunohistochemistry of MPN TMAs are consistent with previously published data. Overall, our results show moderate to good correlation between histological data of WTS and TMA spots illustrating that the TMA technique is applicable to bone marrow biopsies of MPN patients. However, TMA construction in triplicates is necessary to reach sufficient correlation. MPN TMAs can be applied for serial immunohistochemical surveys of archived tissues to assess the mutation status or to further sub-classify MPN cases.

Entities:  

Keywords:  Immunohistochemistry; Myeloproliferative neoplasms; Tissue microarray; Validation

Mesh:

Year:  2016        PMID: 27544663     DOI: 10.1007/s00418-016-1476-x

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  24 in total

Review 1.  Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.

Authors:  L Bubendorf; A Nocito; H Moch; G Sauter
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

2.  The effect of decalcification and choice of fixative on histiocytic iron in bone marrow core biopsies.

Authors:  L DePalma
Journal:  Biotech Histochem       Date:  1996-03       Impact factor: 1.718

3.  Iron deficiency in the Finnish adult population.

Authors:  H Takkunen
Journal:  Scand J Haematol Suppl       Date:  1976

4.  Tissue microarray construction from bone marrow biopsies.

Authors:  Ellen C Obermann; Joerg Marienhagen; Robert Stoehr; Peter H Wuensch; Ferdinand Hofstaedter
Journal:  Biotechniques       Date:  2005-12       Impact factor: 1.993

5.  Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.

Authors:  Eva Fernebro; Michael Dictor; Pär-Ola Bendahl; Mårten Fernö; Mef Nilbert
Journal:  Arch Pathol Lab Med       Date:  2002-06       Impact factor: 5.534

6.  Somatic mutations of calreticulin in myeloproliferative neoplasms.

Authors:  Thorsten Klampfl; Heinz Gisslinger; Ashot S Harutyunyan; Harini Nivarthi; Elisa Rumi; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Bettina Gisslinger; Daniela Pietra; Doris Chen; Gregory I Vladimer; Klaudia Bagienski; Chiara Milanesi; Ilaria Carola Casetti; Emanuela Sant'Antonio; Virginia Ferretti; Chiara Elena; Fiorella Schischlik; Ciara Cleary; Melanie Six; Martin Schalling; Andreas Schönegger; Christoph Bock; Luca Malcovati; Cristiana Pascutto; Giulio Superti-Furga; Mario Cazzola; Robert Kralovics
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

7.  Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia.

Authors:  Konrad Aumann; Anna-Verena Frey; Annette M May; Dieter Hauschke; Clemens Kreutz; Jan P Marx; Jens Timmer; Martin Werner; Heike L Pahl
Journal:  Blood       Date:  2013-05-13       Impact factor: 22.113

8.  Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.

Authors:  Alexandar Tzankov; Annette Zimpfer; Ann-Christine Pehrs; Alessandro Lugli; Philip Went; Robert Maurer; Stefano Pileri; Stephan Dirnhofer
Journal:  Mod Pathol       Date:  2003-11       Impact factor: 7.842

Review 9.  [Histological processing of iliac crest biopsies based on decalcification and paraffin embedding with reference to osteolytic and hematologic diagnosis].

Authors:  H E Schaefer
Journal:  Pathologe       Date:  1995-01       Impact factor: 1.011

10.  A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies.

Authors:  H Stein; R Bob; H Dürkop; C Erck; D Kämpfe; H-M Kvasnicka; H Martens; A Roth; A Streubel
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

View more
  1 in total

1.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2016-11-29       Impact factor: 4.304

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.